5 Oct 2026, 14:24
Securities Administration—
SNTSYNTARA LIMITED
Announcement history available from 1 August 2025
Fromto
5 Oct 2026, 14:21
Securities Administration—
1 Oct 2026, 09:49
Company UpdateMS
21 Sept 2026, 08:45
Company Update—
15 Sept 2026, 10:01
Securities Administration—
15 Sept 2026, 09:58
Meetings & Governance—
27 Aug 2026, 14:50
Company Administration—
27 Aug 2026, 14:49
Financial ResultsMS
28 July 2026, 11:01
Presentations—
27 July 2026, 09:56
Presentations—
27 July 2026, 09:26
Presentations—
27 July 2026, 09:18
Quarterly ReportsMS
20 July 2026, 10:01
Company Update—
6 July 2026, 13:13
Presentations—
6 July 2026, 09:43
Company UpdateMS
3 July 2026, 09:23
Trading Halt / SuspensionMS
2 July 2026, 15:14
Securities Administration—
2 July 2026, 14:59
Securities Administration—
2 July 2026, 14:56
Company Administration—
1 July 2026, 10:01
Company Update—
30 June 2026, 09:36
Substantial Holders—
25 June 2026, 09:18
Securities Administration—
25 June 2026, 09:12
Securities Administration—
23 June 2026, 14:23
Meetings & Governance—
11 June 2026, 09:13
Securities Administration—
10 June 2026, 15:07
Capital RaisingMS
1 June 2026, 11:44
Presentations—
28 May 2026, 10:08
Company Update—
19 May 2026, 10:04
Meetings & Governance—
14 May 2026, 10:02
Securities Administration—
14 May 2026, 09:02
Capital RaisingMS
12 May 2026, 09:57
Substantial Holders—
11 May 2026, 16:36
Substantial Holders—
7 May 2026, 09:32
Securities Administration—
7 May 2026, 09:28
Securities Administration—
30 Apr 2026, 10:51
Presentations—
30 Apr 2026, 10:50
Quarterly ReportsMS
29 Apr 2026, 11:43
Presentations—
29 Apr 2026, 10:21
Securities Administration—
29 Apr 2026, 10:21
Securities Administration—
29 Apr 2026, 10:21
PresentationsMS
29 Apr 2026, 10:21
Capital RaisingMS
28 Apr 2026, 12:06
Company AdministrationMS
28 Apr 2026, 12:06
Company UpdateMS
27 Apr 2026, 09:22
Trading Halt / SuspensionMS
13 Apr 2026, 08:46
Securities Administration—
7 Apr 2026, 13:49
Securities Administration—
25 Mar 2026, 14:29
Presentations—
24 Mar 2026, 08:31
Presentations—
19 Mar 2026, 09:11
Company Update—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 14:24 | Notification regarding unquoted securities - SNT | Securities Administration | — | 06021 | |
| 5 Oct 2026, 14:21 | Notification regarding unquoted securities - SNT | Securities Administration | — | 06021 | |
| 1 Oct 2026, 09:49 | Syntara expands SNT-9465 skin scarring study | Company Update | MS | 11001 | |
| 21 Sept 2026, 08:45 | Syntara receives A$4.7m R&D Tax Incentive | Company Update | — | 11001, 12008 | |
| 15 Sept 2026, 10:01 | Application for quotation of securities - SNT | Securities Administration | — | 06020 | |
| 15 Sept 2026, 09:58 | Notification of 2026 AGM Date | Meetings & Governance | — | 08006 | |
| 27 Aug 2026, 14:50 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 27 Aug 2026, 14:49 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 28 July 2026, 11:01 | Investor Update Webinar Presentation | Presentations | — | 03026, 19009 | |
| 27 July 2026, 09:56 | Investor Update Webinar | Presentations | — | 03027, 14014 | |
| 27 July 2026, 09:26 | Investor Presentation | Presentations | — | 03026 | |
| 27 July 2026, 09:18 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 20 July 2026, 10:01 | AZALOX MDS study advances to final Phase 1b cohort | Company Update | — | 11001 | |
| 6 July 2026, 13:13 | SNT-4728 Webinar Presentation | Presentations | — | 03026 | |
| 6 July 2026, 09:43 | Encouraging SNT-4728 Phase 2 iRBD results | Company Update | MS | 09014, 11001, 14014 | |
| 3 July 2026, 09:23 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 2 July 2026, 15:14 | Notification regarding unquoted securities - SNT | Securities Administration | — | 06021 | |
| 2 July 2026, 14:59 | Application for quotation of securities - SNT | Securities Administration | — | 06020 | |
| 2 July 2026, 14:56 | Proposed issue of securities to the CEO | Company Administration | — | 12008 | |
| 1 July 2026, 10:01 | SNT-9465 scarring trial exceeds 50% enrolment | Company Update | — | 11001 | |
| 30 June 2026, 09:36 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 25 June 2026, 09:18 | Section 708A(5)(e) notice | Securities Administration | — | 06018 | |
| 25 June 2026, 09:12 | Application for quotation of securities - SNT | Securities Administration | — | 06020 | |
| 23 June 2026, 14:23 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 11 June 2026, 09:13 | Application for quotation of securities - SNT | Securities Administration | — | 06020 | |
| 10 June 2026, 15:07 | Results of Share Purchase Plan | Capital Raising | MS | 06017 | |
| 1 June 2026, 11:44 | SNT-4728 webinar presentation | Presentations | — | 03026 | |
| 28 May 2026, 10:08 | SNT-4728 pre-readout informational webinar | Company Update | — | 11001, 14014 | |
| 19 May 2026, 10:04 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 14 May 2026, 10:02 | Update - Proposed issue of securities - SNT | Securities Administration | — | 06013 | |
| 14 May 2026, 09:02 | Share Purchase Plan Offer Booklet | Capital Raising | MS | 06017 | |
| 12 May 2026, 09:57 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 11 May 2026, 16:36 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 7 May 2026, 09:32 | Section 708A(5)(e) notice | Securities Administration | — | 06018 | |
| 7 May 2026, 09:28 | Application for quotation of securities - SNT | Securities Administration | — | 06020 | |
| 30 Apr 2026, 10:51 | Investor Update Webinar | Presentations | — | 03026 | |
| 30 Apr 2026, 10:50 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 11:43 | Investor update webinar | Presentations | — | 14014 | |
| 29 Apr 2026, 10:21 | Proposed issue of securities - SNT | Securities Administration | — | 06013 | |
| 29 Apr 2026, 10:21 | Proposed issue of securities - SNT | Securities Administration | — | 06013 | |
| 29 Apr 2026, 10:21 | Equity Raising Presentation | Presentations | MS | 03026 | |
| 29 Apr 2026, 10:21 | $8m placement and share purchase plan | Capital Raising | MS | 06003, 06017, 09014 | |
| 28 Apr 2026, 12:06 | Continuation of trading halt | Company Administration | MS | 12008 | |
| 28 Apr 2026, 12:06 | Positive FDA feedback for Amsulostat P2b trial | Company Update | MS | 11001 | |
| 27 Apr 2026, 09:22 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 13 Apr 2026, 08:46 | Application for quotation of securities - SNT | Securities Administration | — | 06020 | |
| 7 Apr 2026, 13:49 | Notification regarding unquoted securities - SNT | Securities Administration | — | 06021 | |
| 25 Mar 2026, 14:29 | NWR Virtual Healthcare Conference Presentation | Presentations | — | 03026 | |
| 24 Mar 2026, 08:31 | Syntara to present at NWR Virtual Healthcare Conference | Presentations | — | 14014 | |
| 19 Mar 2026, 09:11 | SNT-4728 milestone payment received from Parkinsons UK | Company Update | — | 11001 |
1–50 of 99
1 / 2